Similarly, studies using diffusion-weighted imaging and perfusion-weighted imaging have also reported a wide range of sensitivities (56–100%) and specificities (63–100%) for distinguishing IDH-mutant from IDH-wild-type gliomas [18,39,40,41]. The gene discussed is IDH2; the disease is central nervous system cancer.